Vishay Intertechnology, Inc. (VSH)

Import this data to Google Sheets with:

=jivedata("VSH","financials")

Full statements spill as a table. For one cell: =jivedata("VSH","Revenue") or =jivedata("VSH","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Vishay Intertechnology, Inc.

VSH • CIK 0000103730

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenues	$3,402,045	$2,937,587	$3,069,048	$3,319,379
Manufacturing Costs	$2,427,552	$2,311,295	$2,474,165	$2,624,739
Gross Profit	$974,493	$626,292	$594,883	$694,640
Selling, General and Administrative Expense	$488,349	$513,564	$538,015	$585,055
Restructuring Charges	—	$40,614	$0	$0
Goodwill, Impairment Loss	$0	$66,487	$0	$0
Operating Income (Loss)	$486,144	$5,627	$56,868	$109,585
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$467,402	$-2,389	$25,513	$72,715
Income Tax Expense (Benefit)	$141,889	$27,366	$34,491	$44,317
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$325,513	$-29,755	$-8,978	$28,398
Net Income (Loss) Attributable to Noncontrolling Interest	$1,693	$1,395	$0	$0
Net Income (Loss) Attributable to Parent	$323,820	$-31,150	$-8,978	$28,398
Weighted Average Number of Shares Outstanding, Basic	139,447,000	136,964,000	135,737,000	136,415,000
Weighted Average Number of Shares Outstanding, Diluted	140,246,000	136,964,000	135,737,000	142,667,000
InterestExpenseNonoperating	—	$27,480	$38,651	$39,579
Other Nonoperating Income (Expense)	$25,263	$19,464	$7,296	$2,709
Gain (Loss) on Extinguishment of Debt	$-18,874	$0	$0	$0
Nonoperating Income (Expense)	$-18,742	$-8,016	$-31,355	$-36,870
Weighted Average Number of Shares Issued, Basic	139,318,000	136,838,000	135,603,000	136,273,000
Incremental Common Shares Attributable to Participating Nonvested Shares with Non-forfeitable Dividend Rights	129,000	126,000	134,000	142,000
Weighted Average Number Diluted Shares Outstanding Adjustment	799,000	0	0	6,252,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$972,719	$590,286	$514,966	$1,297,309
Other Short-term Investments	$35,808	$16,130	$265	$5,263
Accounts Receivable, after Allowance for Credit Loss, Current	$426,674	$401,901	$381,802	$393,373
Operating Lease, Right-of-Use Asset	$126,829	$117,953	$119,746	$122,630
Deferred Income Tax Assets, Net	$137,394	$159,769	$183,016	$190,381
Prepaid Expense and Other Assets, Current	$214,443	$217,809	$231,004	$221,811
Goodwill	$201,416	$179,005	$180,390	$180,027
Assets, Current	$2,297,164	$1,915,507	$1,887,240	$2,724,867
Intangible Assets, Net (Excluding Goodwill)	$72,333	$87,223	$78,487	$71,266
Other Assets, Noncurrent	$110,141	$105,501	$112,122	$117,550
Assets	$4,239,923	$4,110,696	$4,234,160	$5,156,366
Land	$77,006	$84,124	$86,399	$85,711
Buildings and Improvements, Gross	$719,387	$766,058	$839,856	$841,294
Long-term Debt, Excluding Current Maturities	$818,188	$905,019	$950,893	$234,543
Machinery and Equipment, Gross	$3,053,868	$3,259,213	$3,477,884	$3,505,644
Deferred Income Tax Liabilities, Net	$95,776	$96,363	$96,818	$97,488
Construction in Progress, Gross	$290,593	$367,564	$464,475	$558,131
Operating Lease, Liability, Noncurrent	$102,830	$94,218	$95,799	$96,583
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$2,846,208	$2,931,221	$3,195,455	$3,241,135
Other Liabilities, Noncurrent	$87,918	$104,086	$109,228	$136,668
Property, Plant and Equipment, Net	$1,294,646	$1,545,738	$1,673,159	$1,749,645
Liability, Defined Benefit Plan, Noncurrent	$195,503	$173,700	$172,723	$166,246
Liabilities	$2,039,117	$2,081,734	$2,145,887	$2,243,469
Stockholders' Equity Attributable to Noncontrolling Interest	$4,725	$0	—	$0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$2,200,806	$2,028,962	$2,088,273	$2,912,897
Inventory, Finished Goods, Net of Reserves	$167,083	$175,176	$182,444	$184,960
Inventory, Work in Process, Net of Reserves	$267,339	$296,393	$331,347	$360,965
Inventory, Raw Materials, Net of Reserves	$213,098	$217,812	$245,412	$261,186
Inventory, Net	$647,520	$689,381	$759,203	$807,111
Accounts Payable, Current	$191,002	$216,313	$214,984	$237,482
Employee-related Liabilities, Current	$161,940	$137,101	$164,114	$179,479
Operating Lease, Liability, Current	$26,485	$25,901	$26,546	$28,241
Other Liabilities, Current	$239,350	$264,471	$300,031	$310,238
Accrued Income Taxes, Current	$73,098	$64,562	$14,751	$18,757
Liabilities, Current	$691,875	$708,348	$720,426	$1,511,941
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Outstanding	$13,319	$13,361	$12,351	$12,402
Common Stock, Other Value, Outstanding	$1,210	$1,210	$1,210	$1,210
Additional Paid in Capital, Common Stock	$1,291,499	$1,306,245	$1,101,086	$1,945,629
Retained Earnings (Accumulated Deficit)	$1,041,372	$955,500	$892,232	$900,268
Treasury Stock, Common, Value	$161,656	$212,062	$0	$0
Accumulated Other Comprehensive Income (Loss), Net of Tax	$10,337	$-35,292	$81,394	$51,661
Stockholders' Equity Attributable to Parent	$2,196,081	$2,028,962	$2,088,273	$2,912,897
Accounts Receivable, Allowance for Credit Loss, Current	$1,705	$1,311	$2,399	$2,399
Preferred Stock, Shares Authorized	1,000,000	1,000,000	1,000,000	1,000,000
Preferred Stock, Shares Issued	0	0	0	0
Treasury Stock, Common, Shares	7,535,881	9,933,595	0	0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$7,981	$-8,270	$17,966	$-3,841
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$361,894	$-382,433	$-75,320	$823,449
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$972,719	$590,286	$514,966	$384,921
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$325,513	$-29,755	$-8,978	$28,398
Net Cash Provided by (Used in) Operating Activities	$365,703	$173,702	$184,308	$346,029
Payments to Acquire Productive Assets	$329,410	$320,079	$273,293	$352,988
Proceeds from Sale of Property, Plant, and Equipment	$1,156	$3,015	$1,162	$889
Payments to Acquire Businesses, Net of Cash Acquired	$13,753	$216,024	$0	$0
Payments to Acquire Short-term Investments	$117,523	$145,327	$28,575	$5,354
Proceeds from Maturities, Prepayments and Calls of Short-term Investments	$387,898	$164,983	$45,111	$5,973
Payments for (Proceeds from) Other Investing Activities	$1,219	$-970	$2,336	$2,056
Net Cash Provided by (Used in) Investing Activities	$-72,851	$-512,462	$-257,931	$-353,536
Proceeds from Issuance of Long-term Debt	$750,000	$0	$0	$0
Maturities of Senior Debt	—	—	$41,911	$41,911
Repayments of Convertible Debt	$386,745	$52,960	$0	$-41,911
Proceeds from (Repayments of) Lines of Credit	$-42,000	$136,000	$83,000	$53,000
Payment of Financing and Stock Issuance Costs	$26,823	$1,062	$0	$0
Payments for Repurchase of Common Stock	$78,684	$50,406	$12,528	$-10
Payments of Ordinary Dividends, Noncontrolling Interest	$867	$2,500	$0	$0
Payments for Repurchase of Redeemable Noncontrolling Interest	—	$5,500	$0	$0
Payment, Tax Withholding, Share-based Payment Arrangement	$3,994	$4,303	$3,986	$4,042
Proceeds from (Payments for) Other Financing Activities	—	—	$10,000	$9,922
Net Cash Provided by (Used in) Financing Activities	$61,061	$-35,403	$-19,663	$834,797
Depreciation, Depletion and Amortization	$184,373	$210,645	$224,738	$229,323
Gain (Loss) on Disposition of Property Plant Equipment	$554	$1,969	$-100	$-51
Inventory Write-down	$37,426	$37,245	$34,967	$39,394
Goodwill, Impairment Loss	$0	$66,487	$0	$0
Restricted Stock or Unit Expense	$16,532	$20,921	$22,355	$28,577
Gain (Loss) on Extinguishment of Debt	$-18,874	$0	$0	$0
Other Noncash Income (Expense)	$-9,442	$-20,416	$-6,776	$-10,461
Increase (Decrease) in Operating Capital	$161,857	$68,116	$22,844	$-26,166

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("VSH","financials")

Full statements spill as a table. For one cell: =jivedata("VSH","Revenue") or =jivedata("VSH","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.